Inhaler trial aims to reduce lung damage in smokers


Young smokers are being sought to take part in a product trial that may slow lung decline The GSK-funded trial, being run by The George Institute for Global Health, is recruiting people aged 25-45 with the aim to try and slow down lung function decline in smokers, and reduce rates of chronic bronchitis and emphysema.

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Oral, ultra-long-acting medication on the horizon
Next Bring back Advanced Practice Credentialling: NAPSA